<DOC>
	<DOCNO>NCT01452789</DOCNO>
	<brief_summary>The opioid neonatal abstinence syndrome ( NAS ) condition withdrawal symptom utero exposure opioids . In open label Phase 1 trial sublingual buprenorphine associate ~30 % reduction length treatment compare standard care morphine . Due subjective nature score instrument , efficacy blind trial need unequivocally establish superiority buprenorphine morphine . The primary objective trial compare length treatment use sublingual buprenorphine oral morphine solution pharmacologic treatment NAS .</brief_summary>
	<brief_title>Blinded Trial Buprenorphine Morphine Treatment Neonatal Abstinence Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Neonatal Abstinence Syndrome</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>â‰¥ 37 week gestation Exposure opiates utero Demonstration sign symptom neonatal abstinence syndrome require treatment Major congenital malformation and/or intrauterine growth retardation Medical illness require intensification medical therapy . This include , limited suspect sepsis require antibiotic therapy . Hypoglycemia require treatment intravenous dextrose . Bilirubin &gt; 20 mg/dL ( The need phototherapy exclusionary ) Concomitant benzodiazepine severe alcohol abuse , selfreport regular use alcohol benzodiazepine use past 30 day , and/or receipt benzodiazepine prescription ( determine selfreport intake urine ) mother 30 day prior birth , Concomitant use Cytrochrom ( CYP ) 3A inhibitor ( erythromycin , clarithromycin , ketoconazole , itraconazole , HIV protease inhibitor ) inducer ( rifampin , carbamazepine , phenobarbital ) prior initiation NAS treatment Seizure activity neurologic abnormality Breast feeding Inability mother give informed consent due comorbid psychiatric diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>neonatal abstinence syndrome</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>morphine</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>